Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

161 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-grade serous ovarian carcinoma with a sertoliform pattern associated with BRCA mutation: a clinicopathological and molecular analysis.
Travaglino A, Santoro A, Arciuolo D, Raffone A, Scaglione G, D'Alessandris N, Valente M, Sfregola S, Fulgione C, Onori ME, Minucci A, Zannoni GF. Travaglino A, et al. Among authors: scaglione g. Virchows Arch. 2023 Dec;483(6):879-883. doi: 10.1007/s00428-023-03556-z. Epub 2023 May 11. Virchows Arch. 2023. PMID: 37166561
Primary Mucinous Cystadenocarcinoma of the Breast Intermixed with Pleomorphic Invasive Lobular Carcinoma: The First Report of This Rare Association.
Vegni F, D'Alessandris N, Santoro A, Angelico G, Scaglione G, Carlino A, Arciuolo D, Valente M, Sfregola S, Natale M, Sanchez AM, Masciullo V, Zannoni GF, Mulè A. Vegni F, et al. Among authors: scaglione g. J Pers Med. 2023 Jun 3;13(6):948. doi: 10.3390/jpm13060948. J Pers Med. 2023. PMID: 37373937 Free PMC article.
Histopathological and Immunohistochemical Prognostic Factors in High-Grade Non-Endometrioid Carcinomas of the Endometrium (HG-NECs): Is It Possible to Identify Subgroups at Increased Risk?
Paudice M, Biatta CM, Scaglione G, Parodi A, Mammoliti S, Moioli M, Centurioni MG, Barra F, Ferrero S, De Cian F, Mazzocco K, Vellone VG. Paudice M, et al. Among authors: scaglione g. Diagnostics (Basel). 2023 Jun 26;13(13):2171. doi: 10.3390/diagnostics13132171. Diagnostics (Basel). 2023. PMID: 37443564 Free PMC article.
Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial Cancer: A Review on Immunohistochemistry Staining Patterns and Clinical Implications.
Addante F, d'Amati A, Santoro A, Angelico G, Inzani F, Arciuolo D, Travaglino A, Raffone A, D'Alessandris N, Scaglione G, Valente M, Tinnirello G, Sfregola S, Padial Urtueta B, Piermattei A, Cianfrini F, Mulè A, Bragantini E, Zannoni GF. Addante F, et al. Among authors: scaglione g. Int J Mol Sci. 2024 Jan 15;25(2):1056. doi: 10.3390/ijms25021056. Int J Mol Sci. 2024. PMID: 38256131 Free PMC article. Review.
Prognostic Value of Mandard's Tumor Regression Grade (TRG) in Post Chemo-Radiotherapy Cervical Cancer.
Scaglione G, Arciuolo D, Travaglino A, Santoro A, Angelico G, Spadola S, Inzani F, D'Alessandris N, Raffone A, Fulgione C, Padial Urtueta B, Sfregola S, Valente M, Addante F, d'Amati A, Cianfrini F, Piermattei A, Pedone Anchora L, Scambia G, Ferrandina G, Zannoni GF. Scaglione G, et al. Diagnostics (Basel). 2023 Oct 17;13(20):3228. doi: 10.3390/diagnostics13203228. Diagnostics (Basel). 2023. PMID: 37892049 Free PMC article.
Talniflumate abrogates mucin immune suppressive barrier improving efficacy of gemcitabine and nab-paclitaxel treatment in pancreatic cancer.
Agostini A, Guerriero I, Piro G, Quero G, Roberto L, Esposito A, Caggiano A, Priori L, Scaglione G, De Sanctis F, Sistigu A, Musella M, Larghi A, Rizzatti G, Lucchetti D, Alfieri S, Sgambato A, Bria E, Bizzozero L, Arena S, Ugel S, Corbo V, Tortora G, Carbone C. Agostini A, et al. Among authors: scaglione g. J Transl Med. 2023 Nov 23;21(1):843. doi: 10.1186/s12967-023-04733-z. J Transl Med. 2023. PMID: 37996891 Free PMC article.
161 results